Arizona State Retirement System - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 275 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.

Quarter-by-quarter ownership
Arizona State Retirement System ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q2 2024$1,671,978
+1.5%
24,412
+2.6%
0.01%0.0%
Q1 2024$1,647,237
-4.9%
23,804
-1.5%
0.01%
-15.4%
Q4 2023$1,731,485
+35.2%
24,176
-1.6%
0.01%
+18.2%
Q3 2023$1,280,424
-16.0%
24,581
+2.1%
0.01%
-8.3%
Q2 2023$1,525,126
+14.0%
24,086
-2.5%
0.01%0.0%
Q1 2023$1,337,343
+5.4%
24,697
+3.0%
0.01%0.0%
Q4 2022$1,268,704
+18.2%
23,974
+3.9%
0.01%
+9.1%
Q3 2022$1,073,000
-16.5%
23,069
+2.4%
0.01%
-8.3%
Q2 2022$1,285,000
-5.2%
22,519
+1.7%
0.01%
+9.1%
Q1 2022$1,355,000
+39.1%
22,136
+19.0%
0.01%
+57.1%
Q4 2021$974,000
+38.9%
18,609
-1.0%
0.01%
+16.7%
Q3 2021$701,000
-8.1%
18,801
+0.6%
0.01%0.0%
Q2 2021$763,000
+7.0%
18,696
-11.0%
0.01%0.0%
Q1 2021$713,000
+8.9%
21,001
+1.9%
0.01%0.0%
Q4 2020$655,000
+41.5%
20,612
+14.2%
0.01%
+20.0%
Q3 2020$463,000
+33.0%
18,045
+33.2%
0.01%0.0%
Q2 2020$348,000
+64.2%
13,549
-1.7%
0.01%
+25.0%
Q1 2020$212,00013,7890.00%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q3 2022
NameSharesValueWeighting ↓
DCF Advisers, LLC 375,000$15,308,0005.42%
SILVERARC CAPITAL MANAGEMENT, LLC 113,258$4,623,0002.06%
Tri Locum Partners LP 150,783$6,155,0002.02%
COOPER/HAIMS ADVISORS, LLC 61,116$2,495,0001.64%
Vantage Consulting Group Inc 226,670$9,252,0001.61%
Nicholas Investment Partners, LP 598,261$24,421,0001.53%
Bellevue Group AG 3,609,919$147,357,0001.44%
GENERAL AMERICAN INVESTORS CO INC 350,804$14,320,0001.20%
Rhenman & Partners Asset Management AB 429,728$17,541,0001.19%
WASATCH ADVISORS LP 6,506,789$265,607,0001.08%
View complete list of INTRA CELLULAR THERAPIES INC shareholders